praziquantel has been researched along with Infection Reactivation in 9 studies
azinox: Russian drug
| Excerpt | Relevance | Reference |
|---|---|---|
| "Schistosomiasis control relies on praziquantel for preventive chemotherapy." | 9.69 | SCHISTOACT: a protocol for an open-label, five-arm, non-inferiority, individually randomized controlled trial of the efficacy and safety of praziquantel plus artemisinin-based combinations in the treatment of Schistosoma mansoni infection. ( Muok, EMO; Obonyo, CO; Wamae, P; Were, VO, 2023) |
| "Schistosomiasis control relies on praziquantel for preventive chemotherapy." | 5.69 | SCHISTOACT: a protocol for an open-label, five-arm, non-inferiority, individually randomized controlled trial of the efficacy and safety of praziquantel plus artemisinin-based combinations in the treatment of Schistosoma mansoni infection. ( Muok, EMO; Obonyo, CO; Wamae, P; Were, VO, 2023) |
| "While praziquantel mass drug administration is currently the most widely used method in the control of human schistosomiasis, it does not prevent subsequent reinfection hence persistent transmission." | 5.05 | A systematic review and meta-analysis on the rate of human schistosomiasis reinfection. ( Makene, T; Mushi, V; Zacharia, A, 2020) |
| "Praziquantel (PZQ) has been extensively used as the drug of choice for the treatment of schistosomiasis on account of its safety and effectiveness against all major forms of schistosomiasis." | 3.01 | Praziquantel efficacy, urinary and intestinal schistosomiasis reinfection - a systematic review. ( Aboagye, IF; Addison, YAA, 2023) |
| "Praziquantel has an impact on reducing the prevalence and intensity of urogenital schistosomiasis." | 1.72 | Urogenital schistosomiasis in three different water access in the Senegal river basin: prevalence and monitoring praziquantel efficacy and re-infection levels. ( Boissier, J; Diop, B; Doucouré, S; Mathieu-Begné, E; Rey, O; Sène, M; Senghor, B; Sokhna, C; Sow, D, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 9 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asuming-Brempong, EK | 1 |
| Ayi, I | 1 |
| van der Puije, W | 1 |
| Gyan, BA | 1 |
| Larbi, IA | 1 |
| Ashong, Y | 1 |
| Frempong, NA | 1 |
| Quartey, JK | 1 |
| Otchere, J | 1 |
| Jones, FM | 1 |
| Wilson, S | 1 |
| Dunne, DW | 1 |
| Boakye, DA | 1 |
| Aboagye, IF | 3 |
| Addison, YAA | 3 |
| Senghor, B | 1 |
| Mathieu-Begné, E | 1 |
| Rey, O | 1 |
| Doucouré, S | 1 |
| Sow, D | 1 |
| Diop, B | 1 |
| Sène, M | 1 |
| Boissier, J | 1 |
| Sokhna, C | 1 |
| Obonyo, CO | 1 |
| Were, VO | 1 |
| Wamae, P | 1 |
| Muok, EMO | 1 |
| Worasith, C | 1 |
| Wangboon, C | 1 |
| Kopolrat, KY | 1 |
| Homwong, C | 1 |
| Sithithaworn, J | 1 |
| Techasen, A | 1 |
| Thanan, R | 1 |
| Khuntikeo, N | 1 |
| Sithithaworn, P | 1 |
| Zacharia, A | 1 |
| Mushi, V | 1 |
| Makene, T | 1 |
| Wu, HW | 1 |
| Park, S | 1 |
| Pond-Tor, S | 1 |
| Stuart, R | 1 |
| Zhou, S | 1 |
| Hong, Y | 1 |
| Ruiz, AE | 1 |
| Acosta, L | 1 |
| Jarilla, B | 1 |
| Friedman, JF | 1 |
| Jiz, M | 1 |
| Kurtis, JD | 1 |
| Songserm, N | 1 |
| Namwong, W | 1 |
| Woradet, S | 1 |
| Sripa, B | 1 |
| Ali, A | 1 |
| Mohammed, ES | 1 |
| El-Dakhly, KM | 1 |
2 reviews available for praziquantel and Infection Reactivation
| Article | Year |
|---|---|
Praziquantel efficacy, urinary and intestinal schistosomiasis reinfection - a systematic review.
Topics: Anthelmintics; Child; Humans; Praziquantel; Reinfection; Schistosomiasis haematobia; Schistosomiasis | 2023 |
Praziquantel efficacy, urinary and intestinal schistosomiasis reinfection - a systematic review.
Topics: Anthelmintics; Child; Humans; Praziquantel; Reinfection; Schistosomiasis haematobia; Schistosomiasis | 2023 |
Praziquantel efficacy, urinary and intestinal schistosomiasis reinfection - a systematic review.
Topics: Anthelmintics; Child; Humans; Praziquantel; Reinfection; Schistosomiasis haematobia; Schistosomiasis | 2023 |
Praziquantel efficacy, urinary and intestinal schistosomiasis reinfection - a systematic review.
Topics: Anthelmintics; Child; Humans; Praziquantel; Reinfection; Schistosomiasis haematobia; Schistosomiasis | 2023 |
Praziquantel efficacy, urinary and intestinal schistosomiasis reinfection - a systematic review.
Topics: Anthelmintics; Child; Humans; Praziquantel; Reinfection; Schistosomiasis haematobia; Schistosomiasis | 2023 |
Praziquantel efficacy, urinary and intestinal schistosomiasis reinfection - a systematic review.
Topics: Anthelmintics; Child; Humans; Praziquantel; Reinfection; Schistosomiasis haematobia; Schistosomiasis | 2023 |
Praziquantel efficacy, urinary and intestinal schistosomiasis reinfection - a systematic review.
Topics: Anthelmintics; Child; Humans; Praziquantel; Reinfection; Schistosomiasis haematobia; Schistosomiasis | 2023 |
Praziquantel efficacy, urinary and intestinal schistosomiasis reinfection - a systematic review.
Topics: Anthelmintics; Child; Humans; Praziquantel; Reinfection; Schistosomiasis haematobia; Schistosomiasis | 2023 |
Praziquantel efficacy, urinary and intestinal schistosomiasis reinfection - a systematic review.
Topics: Anthelmintics; Child; Humans; Praziquantel; Reinfection; Schistosomiasis haematobia; Schistosomiasis | 2023 |
A systematic review and meta-analysis on the rate of human schistosomiasis reinfection.
Topics: Animals; Biometry; Humans; Praziquantel; Reinfection; Schistosoma; Schistosomiasis | 2020 |
2 trials available for praziquantel and Infection Reactivation
| Article | Year |
|---|---|
SCHISTOACT: a protocol for an open-label, five-arm, non-inferiority, individually randomized controlled trial of the efficacy and safety of praziquantel plus artemisinin-based combinations in the treatment of Schistosoma mansoni infection.
Topics: Adult; Animals; Anthelmintics; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Equivalen | 2023 |
Public health interventions for preventing re-infection of Opisthorchis viverrini: application of the self-efficacy theory and group process in high-prevalent areas of Thailand.
Topics: Adult; Animals; Anthelmintics; Feces; Female; Humans; Male; Opisthorchiasis; Opisthorchis; Praziquan | 2021 |
5 other studies available for praziquantel and Infection Reactivation
| Article | Year |
|---|---|
Increased ShTAL1 IgE responses post-Praziquantel treatment may be associated with a reduced risk to re-infection in a Ghanaian S. haematobium-endemic community.
Topics: Allergens; Animals; Anthelmintics; Female; Ghana; Humans; Immunoglobulin E; Immunoglobulin G; Male; | 2022 |
Urogenital schistosomiasis in three different water access in the Senegal river basin: prevalence and monitoring praziquantel efficacy and re-infection levels.
Topics: Animals; Anthelmintics; Child; Child, Preschool; Humans; Praziquantel; Prevalence; Reinfection; Rive | 2022 |
Application of urine antigen assay to evaluate outcomes of praziquantel treatment and reinfection in opisthorchiasis in northeast Thailand.
Topics: Animals; Antigens, Helminth; Feces; Humans; Opisthorchiasis; Opisthorchis; Praziquantel; Prospective | 2020 |
Whole-Proteome Differential Screening Identifies Novel Vaccine Candidates for Schistosomiasis japonica.
Topics: Animals; Antibodies, Helminth; Disease Resistance; Humans; Neoplasm Recurrence, Local; Praziquantel; | 2021 |
Serine protease inhibitor, serpin, is a biomarker following Schistosoma mansoni re-infection in mice.
Topics: Animals; Anthelmintics; Biomarkers; Mice; Praziquantel; Reinfection; Schistosoma mansoni; Schistosom | 2021 |